AT Bancorp’s Calumet Specialty Products CLMT Stock Holding History

AT Bancorp’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,400	Closed	-$10K	–	239
2017 Q2	$10K	Buy	+2,400	New	+$9.63K	﹤0.01%	293

Other funds holding CLMT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

SCM

Springhouse Capital Management Westport, Connecticut $55.3M AUM 20.84% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

SPCM

Sound Point Capital Management New York $28.3M AUM 13.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AT Bancorp's CLMT Position: Q3 2017 in Review

AT Bancorp sold out of Calumet Specialty Products (CLMT) in Q3 2017, closing a stake of 2,400 shares — an estimated $10K sold.

AT Bancorp first reported a position in CLMT in Q2 2017 and held it in 1 quarter. The position peaked at $10K in Q2 2017. 72 funds tracked by Wall St. Rank hold CLMT as of Q3 2017.

AT Bancorp reported no remaining Calumet Specialty Products position as of Q3 2017 after selling out during the quarter.
AT Bancorp sold 2,400 Calumet Specialty Products shares in Q3 2017, an estimated $10K.
AT Bancorp first reported a position in Calumet Specialty Products in Q2 2017 and held it in 1 quarter.
AT Bancorp's Calumet Specialty Products position peaked at $10K in Q2 2017.
72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2017.

Based on AT Bancorp's 13F filing for Q3 2017, filed 8 Nov 2017.